The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma: Laboratory investigation

Journal of Neurosurgery

Volumn 113, Issue 2, 2010, Pages 225-233

  Lu, Jie ^a   Zhuang, Zhengping ^a   Song, Debbie K ^a   Mehta, Gautam U ^a   Ikejiri, Barbara ^a   Mushlin, Harry ^a   Park, Deric M ^b   Lonser, Russell R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Glioma; Nuclear receptor corepressor; Phosphorylation; Protein phosphatase 2A; Xenograft

Indexed keywords

LB 1; NUCLEAR RECEPTOR COREPRESSOR; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER STEM CELL; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFICACY; GLIOBLASTOMA; GLIOMA; IC 50; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT OUTCOME; TUMOR CELL; TUMOR VOLUME;

ACETYLATION; ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; ENZYME INHIBITORS; GLIOMA; HISTONES; HUMANS; MICE; MICE, SCID; NUCLEAR RECEPTOR CO-REPRESSOR 1; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955595320     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2009.11.JNS091272     Document Type: Article

References (18)

1. Andrabi S, Gjoerup OV, Kean JA, Roberts TM, Schaffhausen B: Protein phosphatase 2A regulates life and death decisions via Akt in a context-dependent manner. Proc Natl Acad Sci U S A 104:19011-19016, 2007
2. Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, et al: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60:5165-5170, 2000
3. Fingar DC, Richardson CJ, Tee AR, Cheatham L, Tsou C, Blenis J: mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E. Mol Cell Biol 24:200-216, 2004
4. Guertin DA, Sabatini DM: An expanding role for mTOR in cancer. Trends Mol Med 11:353-361, 2005
5. Hartman HB, Yu J, Alenghat T, Ishizuka T, Lazar MA: The histone-binding code of nuclear receptor co-repressors matches the substrate specificity of histone deacetylase 3. EMBO Rep 6:445-451, 2005
6. Hermanson O, Jepsen K, Rosenfeld MG: N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419:934-939, 2002
7. Janssens V, Goris J: Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353:417-439, 2001
8. Li J, Wang J, Wang J, Nawaz Z, Liu JM, Qin J, et al: Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J 19:4342-4350, 2000
9. Manoukian AS, Woodgett JR: Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways. Adv Cancer Res 84:203-229, 2002
10. Miller FD, Gauthier AS: Timing is everything: making neurons versus glia in the developing cortex. Neuron 54:357-369, 2007
11. Moyal EC, Laprie A, Delannes M, Poublanc M, Catalaa I, Dalenc F, et al: Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 68:1396-1401, 2007
12. Ng AP, Nin DS, Fong JH, Venkataraman D, Chen CS, Khan M: Therapeutic targeting of nuclear receptor corepressor misfolding in acute promyelocytic leukemia cells with genistein. Mol Cancer Ther 6:2240-2248, 2007
13. Park DM, Li J, Okamoto H, Akeju O, Kim SH, Lubensky I, et al: N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle 6:467-470, 2007
14. Platta CS, Greenblatt DY, Kunnimalaiyaan M, Chen H: Valproic acid induces Notch1 signaling in small cell lung cancer cells. J Surg Res 148:31-37, 2008
15. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al: Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828, 2003
16. Stupp R, Hegi ME: Targeting brain-tumor stem cells. Nat Biotechnol 25:193-194, 2007
17. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al : Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005
18. Yamamoto S, Tanaka K, Sakimura R, Okada T, Nakamura T, Li Y, et al: Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines. Anticancer Res 28 (3A):1585-1591, 2008